Literature DB >> 25951993

Striatal-enriched protein tyrosine phosphatase regulates the PTPα/Fyn signaling pathway.

Jian Xu1, Pradeep Kurup1, Ethan Foscue1, Paul J Lombroso1.   

Abstract

The tyrosine kinase Fyn has two regulatory tyrosine residues that when phosphorylated either activate (Tyr(420)) or inhibit (Tyr(531)) Fyn activity. Within the central nervous system, two protein tyrosine phosphatases (PTPs) target these regulatory tyrosines in Fyn. PTPα dephosphorylates Tyr(531) and activates Fyn, while STEP (STriatal-Enriched protein tyrosine Phosphatase) dephosphorylates Tyr(420) and inactivates Fyn. Thus, PTPα and STEP have opposing functions in the regulation of Fyn; however, whether there is cross talk between these two PTPs remains unclear. Here, we used molecular techniques in primary neuronal cultures and in vivo to demonstrate that STEP negatively regulates PTPα by directly dephosphorylating PTPα at its regulatory Tyr(789). Dephosphorylation of Tyr(789) prevents the translocation of PTPα to synaptic membranes, blocking its ability to interact with and activate Fyn. Genetic or pharmacologic reduction in STEP61 activity increased the phosphorylation of PTPα at Tyr(789), as well as increased translocation of PTPα to synaptic membranes. Activation of PTPα and Fyn and trafficking of GluN2B to synaptic membranes are necessary for ethanol (EtOH) intake behaviors in rodents. We tested the functional significance of STEP61 in this signaling pathway by EtOH administration to primary cultures as well as in vivo, and demonstrated that the inactivation of STEP61 by EtOH leads to the activation of PTPα, its translocation to synaptic membranes, and the activation of Fyn. These findings indicate a novel mechanism by which STEP61 regulates PTPα and suggest that STEP and PTPα coordinate the regulation of Fyn. STEP61 , PTPα, Fyn, and NMDA receptor (NMDAR) have been implicated in ethanol intake behaviors in the dorsomedial striatum (DMS) in rodents. Here, we report that PTPα is a novel substrate for STEP61. Upon ethanol exposure, STEP61 is phosphorylated and inactivated by protein kinase A (PKA) signaling in the DMS. As a result of STEP61 inhibition, there is an increase in the phosphorylation of PTPα, which translocates to lipid rafts and activates Fyn and subsequent NMDAR signaling. The results demonstrate a synergistic regulation of Fyn-NMDAR signaling by STEP61 and PTPα, which may contribute to the regulation of ethanol-related behaviors. NMDA, N-methyl-D-aspartate; PTPα, receptor-type protein tyrosine phosphatase alpha; STEP, STriatal-Enriched protein tyrosine Phosphatase.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  PTPα; STEP; dephosphorylation; dorsomedial striatum; ethanol administration; lipid rafts

Mesh:

Substances:

Year:  2015        PMID: 25951993      PMCID: PMC4516628          DOI: 10.1111/jnc.13160

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  76 in total

1.  Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum.

Authors:  P J Lombroso; G Murdoch; M Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  STEP61: a member of a family of brain-enriched PTPs is localized to the endoplasmic reticulum.

Authors:  A Bult; F Zhao; R Dirkx; E Sharma; E Lukacsi; M Solimena; J R Naegele; P J Lombroso
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

3.  A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures.

Authors:  P J Lombroso; J R Naegele; E Sharma; M Lerner
Journal:  J Neurosci       Date:  1993-07       Impact factor: 6.167

4.  Protein tyrosine phosphatase alpha regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts.

Authors:  Lola Maksumova; Hoa T Le; Farkhad Muratkhodjaev; Dominique Davidson; André Veillette; Catherine J Pallen
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

5.  Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts.

Authors:  J Su; M Muranjan; J Sap
Journal:  Curr Biol       Date:  1999-05-20       Impact factor: 10.834

6.  APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes.

Authors:  Jun Liu; Akiko Kimura; Christian A Baumann; Alan R Saltiel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

7.  Downstream effects of striatal-enriched protein tyrosine phosphatase reduction on RNA expression in vivo and in vitro.

Authors:  V L Reinhart; T Nguyen; R Gerwien; M Kuhn; P D Yates; T A Lanz
Journal:  Neuroscience       Date:  2014-08-15       Impact factor: 3.590

8.  Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination.

Authors:  Pei-Shan Wang; Jing Wang; Zhi-Cheng Xiao; Catherine J Pallen
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

9.  Neural recognition molecules CHL1 and NB-3 regulate apical dendrite orientation in the neocortex via PTP alpha.

Authors:  Haihong Ye; Yen Ling Jessie Tan; Sathivel Ponniah; Yasuo Takeda; Shi-Qiang Wang; Melitta Schachner; Kazutada Watanabe; Catherine J Pallen; Zhi-Cheng Xiao
Journal:  EMBO J       Date:  2007-11-29       Impact factor: 11.598

10.  RPTPalpha is essential for NCAM-mediated p59fyn activation and neurite elongation.

Authors:  Vsevolod Bodrikov; Iryna Leshchyns'ka; Vladimir Sytnyk; John Overvoorde; Jeroen den Hertog; Melitta Schachner
Journal:  J Cell Biol       Date:  2004-12-28       Impact factor: 10.539

View more
  18 in total

1.  Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels.

Authors:  Jian Xu; Pradeep Kurup; Garikoitz Azkona; Tyler D Baguley; Ana Saavedra; Angus C Nairn; Jonathan A Ellman; Esther Pérez-Navarro; Paul J Lombroso
Journal:  J Neurochem       Date:  2015-09-17       Impact factor: 5.372

Review 2.  Molecular mechanisms underlying alcohol-drinking behaviours.

Authors:  Dorit Ron; Segev Barak
Journal:  Nat Rev Neurosci       Date:  2016-07-21       Impact factor: 34.870

3.  Xanthoceraside modulates NR2B-containing NMDA receptors at synapses and rescues learning-memory deficits in APP/PS1 transgenic mice.

Authors:  Lin Zhu; Lei Yang; Xuemei Zhao; Danyang Liu; Xiaoli Guo; Peng Liu; Tianyan Chi; Xuefei Ji; Libo Zou
Journal:  Psychopharmacology (Berl)       Date:  2017-11-09       Impact factor: 4.530

Review 4.  Alcohol-dependent molecular adaptations of the NMDA receptor system.

Authors:  N Morisot; D Ron
Journal:  Genes Brain Behav       Date:  2017-01       Impact factor: 3.449

5.  Altered Intracellular Calcium Homeostasis Underlying Enhanced Glutamatergic Transmission in Striatal-Enriched Tyrosine Phosphatase (STEP) Knockout Mice.

Authors:  Federica Bosco; Pierluigi Valente; Marco Milanese; Alessandra Piccini; Mirko Messa; Giambattista Bonanno; Paul Lombroso; Pietro Baldelli; Fabio Benfenati; Silvia Giovedì
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

6.  Inhibition of striatal-enriched protein tyrosine phosphatase (STEP) activity reverses behavioral deficits in a rodent model of autism.

Authors:  Manavi Chatterjee; Priya Singh; Jian Xu; Paul J Lombroso; Pradeep K Kurup
Journal:  Behav Brain Res       Date:  2020-05-24       Impact factor: 3.332

7.  Dopamine D2 receptors are involved in the regulation of Fyn and metabotropic glutamate receptor 5 phosphorylation in the rat striatum in vivo.

Authors:  Li-Min Mao; John Q Wang
Journal:  J Neurosci Res       Date:  2016-01-17       Impact factor: 4.164

8.  Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice.

Authors:  Jian Xu; Pradeep Kurup; Tyler D Baguley; Ethan Foscue; Jonathan A Ellman; Angus C Nairn; Paul J Lombroso
Journal:  Cell Mol Life Sci       Date:  2015-10-08       Impact factor: 9.261

Review 9.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 10.  Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease.

Authors:  Pranesh Padmanabhan; Andrew Kneynsberg; Jürgen Götz
Journal:  Nat Rev Neurosci       Date:  2021-11-01       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.